نتائج البحث - "Alena Zalutskaya"

1

دورية أكاديمية

Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic

المؤلفون: Walid Kamoun, Elden Swindell, Christine Pien, Lia Luus, Jason Cain, Minh Pham, Irawati Kandela, Zhaohua Richard Huang, Suresh K. Tipparaju, Alexander Koshkaryev, Vasileios Askoxylakis, Dmitri B. Kirpotin, Troy Bloom, Mari Mino-Kenudson, James D. Marks, Alena Zalutskaya, Wiam Bshara, Carl Morrison, Daryl C. Drummond

المصدر: Pharmaceutics, Vol 12, Iss 10, p 996 (2020)

مصطلحات موضوعية: bladder cancer, EphA2, antibody directed nanotherapeutic, liposomes, immunoliposomes, nanocarrier, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1999-4923/12/10/996; https://doaj.org/toc/1999-4923

URL الوصول: https://doaj.org/article/8d1191f930f84ed890aae26feb4148ee

Find this article in full text from ProQuest

Full Text Finder

2

Patient-reported outcomes (PROS) from patients with RET-mutant medullary thyroid cancer (MTC) and ret fusion-positive TC treated with pralsetinib in the arrow trial

المؤلفون: Julien Hadoux, Hu Mimi I, Brose Marcia S., Elena Garralda, Christine Spitzweg, Noemi Reguart, Cao Christine Do, Forster Martin D., Teresa Alonso-Gordoa, Teresa Barata, Astrid Scalori, Alena Zalutskaya, Peter Trask, Vivek Subbiah

المصدر: Endocrine Abstracts.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2a926f049428e05f022627767116a8cc
https://doi.org/10.1530/endoabs.84.ps3-15-134

3

Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer

المصدر: Journal of medicinal chemistry. 65(14)

مصطلحات موضوعية: ErbB Receptors, Lung Neoplasms, Drug Resistance, Neoplasm, Carcinoma, Non-Small-Cell Lung, Drug Discovery, Mutation, Molecular Medicine, Humans, Protein Kinase Inhibitors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a80b3cdcda4b5b59447b540cafce20
https://pubmed.ncbi.nlm.nih.gov/35838760

Find this issue from the American Chemical Society

4

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

المؤلفون: Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano

المساهمون: Institut Català de la Salut, [Subbiah V] The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [Cassier PA] Centre Léon Bérard, Lyon, France. [Siena S] Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale) and Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy. [Garralda E] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Paz-Ares L] Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Ciberonc and Complutense University, Madrid, Spain. [Garrido P] IRYCIS Hospital Universitario Ramón y Cajal, Ciberonc and Alcalá University, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Oncogens, Settore MED/06 - Oncologia Medica, Pyridines, Càncer - Tractament, Proto-Oncogene Proteins c-ret, Genetic Phenomena::Recombination, Genetic::Gene Fusion::Oncogene Fusion [PHENOMENA AND PROCESSES], Medizin, Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], General Medicine, Other subheadings::Other subheadings::/drug therapy [Other subheadings], General Biochemistry, Genetics and Molecular Biology, Neoplasms [DISEASES], neoplasias [ENFERMEDADES], Pyrimidines, Neoplasms, fenómenos genéticos::recombinación genética::fusión génica::fusión de oncogenes [FENÓMENOS Y PROCESOS], Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptor Protein-Tyrosine Kinases [CHEMICALS AND DRUGS], Humans, Pyrazoles, aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores proteína-tirosina cinasas [COMPUESTOS QUÍMICOS Y DROGAS], Gene Fusion